Whistleblower's Cephalon FCA Suit Headed To Pa. Court
A New York federal judge on Wednesday agreed to move a whistleblower suit alleging Cephalon Inc. promoted some of its drugs for off-label uses to boost sales to government-funded programs, finding...To view the full article, register now.
Already a subscriber? Click here to view full article